Ethanol-induced liver fibrosis in rats fed high fat diet.

PubWeight™: 1.48‹?› | Rank: Top 4%

🔗 View Article (PMID 3758935)

Published in Hepatology on November 03, 1986

Authors

H Tsukamoto, S J Towner, L M Ciofalo, S W French

Articles citing this

Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog. Proc Natl Acad Sci U S A (2009) 2.07

Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest (1995) 1.98

Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol (1993) 1.75

Alcohol-induced generation of lipid peroxidation products in humans. J Clin Invest (1999) 1.55

Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence. Hepatology (2008) 1.47

Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids. J Hepatol (2008) 1.23

Mouse intragastric infusion (iG) model. Nat Protoc (2012) 1.19

The effect of inflammatory cytokines in alcoholic liver disease. Mediators Inflamm (2013) 1.18

"Second hit" models of alcoholic liver disease. Semin Liver Dis (2009) 1.12

Transcription factors nuclear factor I and Sp1 interact with the murine collagen alpha 1 (I) promoter. Mol Cell Biol (1991) 1.12

Reactive free radical generation in vivo in heart and liver of ethanol-fed rats: correlation with radical formation in vitro. Proc Natl Acad Sci U S A (1987) 1.12

Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis. Am J Pathol (2008) 1.11

Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition. Free Radic Biol Med (2005) 1.08

Potentiation of ethanol-induced pancreatic injury by dietary fat. Induction of chronic pancreatitis by alcohol in rats. Am J Pathol (1988) 1.03

Laboratory models available to study alcohol-induced organ damage and immune variations: choosing the appropriate model. Alcohol Clin Exp Res (2010) 1.01

Dynamic adaptation of liver mitochondria to chronic alcohol feeding in mice: biogenesis, remodeling, and functional alterations. J Biol Chem (2012) 0.99

Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: An important role for CXCL1. Hepatology (2015) 0.98

Role of the Ito cell in liver parenchymal fibrosis in rats fed alcohol and a high fat-low protein diet. Am J Pathol (1988) 0.94

CD14 and lipopolysaccharide binding protein expression in a rat model of alcoholic liver disease. Am J Pathol (1998) 0.93

Effects of long-term ethanol administration in a rat total enteral nutrition model of alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol (2010) 0.90

Effect of resveratrol on alcohol-induced mortality and liver lesions in mice. BMC Gastroenterol (2006) 0.90

Activation of hepatic stellate cell in Pten null liver injury model. Fibrogenesis Tissue Repair (2016) 0.80

Alcohol cirrhosis alters nuclear receptor and drug transporter expression in human liver. Drug Metab Dispos (2013) 0.80

Alterations in glucose transporter proteins in alcoholic liver disease in the rat. Am J Pathol (1995) 0.79

Taurine Attenuates Hepatic Inflammation in Chronic Alcohol-Fed Rats Through Inhibition of TLR4/MyD88 Signaling. J Med Food (2015) 0.76

Plasma lipid profiling of different types of hepatic fibrosis induced by carbon tetrachloride and lomustine in rats. Lipids Health Dis (2016) 0.76

Rodent models of alcoholic liver disease. Int J Exp Pathol (1994) 0.76

Thromboxane inhibitors attenuate inflammatory and fibrotic changes in rat liver despite continued ethanol administrations. Alcohol Clin Exp Res (2012) 0.75

A neurotoxic alcohol exposure paradigm does not induce hepatic encephalopathy. Neurotoxicol Teratol (2016) 0.75

Mitochondrial remodeling in the liver following chronic alcohol feeding to rats. Free Radic Biol Med (2016) 0.75

Low-ω3 Fatty Acid and Soy Protein Attenuate Alcohol-Induced Fatty Liver and Injury by Regulating the Opposing Lipid Oxidation and Lipogenic Signaling Pathways. Oxid Med Cell Longev (2016) 0.75

Insulin resistance in clinical and experimental alcoholic liver disease. Ann N Y Acad Sci (2015) 0.75

Effect of iron on cholesterol 7-alpha-hydroxylase expression in alcohol-induced hepatic steatosis in mouse. J Lipid Res (2017) 0.75

Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity. J Clin Transl Res (2017) 0.75

Articles by these authors

Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet (2001) 3.21

Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem (2000) 2.58

Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res (1989) 2.18

Analgesic effect of morphine glucuronides. Tohoku J Exp Med (1971) 2.02

Experimental models of hepatic fibrosis: a review. Semin Liver Dis (1990) 1.81

Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119) Hepatology (1991) 1.78

Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology (2000) 1.73

Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond) (2006) 1.73

Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide. Gastroenterology (1999) 1.71

Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology (1990) 1.68

Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275. Gastroenterology (1993) 1.52

Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol (1991) 1.51

Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver (1989) 1.50

Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells. Infect Immun (2000) 1.48

Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am J Physiol Gastrointest Liver Physiol (2000) 1.48

Three distinct forms of type 2A protein phosphatase in human erythrocyte cytosol. J Biol Chem (1988) 1.45

Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. Prostaglandins Leukot Essent Fatty Acids (2001) 1.42

Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology (1996) 1.41

Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the twitcher mouse, a model of Krabbe's disease. J Neurochem (1996) 1.37

Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. Hepatology (1997) 1.37

Clinically silent primary adrenal lymphoma: a case report and review of the literature. Am J Hematol (1998) 1.36

Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology (1996) 1.35

Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem (1998) 1.33

Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet. Hepatology (1985) 1.33

Mallory body induction in drug-primed mouse liver. Hepatology (1996) 1.30

Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: status report. Hepatology (1990) 1.28

Cyclical pattern of blood alcohol levels during continuous intragastric ethanol infusion in rats. Alcohol Clin Exp Res (1985) 1.28

Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages. Am J Physiol (1997) 1.24

Ultrastructural localization of actin-like filaments in rat hepatocytes. Gastroenterology (1975) 1.24

Dietary factors and alcoholic cirrhosis. Alcohol Clin Exp Res (1986) 1.24

Models of alcoholic liver disease in rodents: a critical evaluation. Alcohol Clin Exp Res (2001) 1.23

Metabolism of drugs. LIX. A new metabolite of antipyrine. Biochem Pharmacol (1968) 1.23

Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem Biophys Res Commun (1992) 1.23

Role of cytochrome P-450 2E1 in ethanol-, carbon tetrachloride- and iron-dependent microsomal lipid peroxidation. Hepatology (1992) 1.22

Reduced susceptibility of mice overexpressing transforming growth factor alpha to dextran sodium sulphate induced colitis. Gut (1998) 1.21

Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proc Soc Exp Biol Med (2000) 1.21

Mitochondrial glutathione depletion in alcoholic liver disease. Alcohol (1994) 1.20

Iron primes hepatic macrophages for NF-kappaB activation in alcoholic liver injury. Am J Physiol (1999) 1.20

Mechanism of the alcohol cyclic pattern: role of the hypothalamic-pituitary-thyroid axis. Am J Physiol Gastrointest Liver Physiol (2000) 1.20

hnRNP A2 and hnRNP L bind the 3'UTR of glucose transporter 1 mRNA and exist as a complex in vivo. Biochem Biophys Res Commun (1999) 1.19

Isolation and properties of suppressor-sensitive mutants of Bacillus subtilis bacteriophage SP02. J Virol (1970) 1.18

Metabolism of drugs. LXX. Further study on antipyrine metabolism. Chem Pharm Bull (Tokyo) (1971) 1.17

Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology (1995) 1.16

Long-term cannulation model for blood sampling and intragastric infusion in the rat. Am J Physiol (1984) 1.15

Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. Hepatology (1992) 1.14

The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol. Biochem Biophys Res Commun (2000) 1.13

Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Lab Invest (1988) 1.12

Wnt signaling regulates hemopoiesis through stromal cells. J Immunol (2001) 1.11

A method of isolation of Mallory bodies in a purified fraction. Lab Invest (1972) 1.11

Outside-to-inside signal through the membrane TNF-alpha induces E-selectin (CD62E) expression on activated human CD4+ T cells. J Immunol (2001) 1.10

Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. Arthritis Rheum (2001) 1.10

Does gastrojejunostomy for unresectable cancer of the gastric antrum offer satisfactory palliation? Hepatogastroenterology (1999) 1.10

TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma. Lab Invest (2001) 1.10

The role of the Ito cell in perivenular and intralobular fibrosis in alcoholic hepatitis. Arch Pathol Lab Med (1983) 1.09

The Mallory body: structure, composition, and pathogenesis. Hepatology (1981) 1.08

Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis. Alcohol (1994) 1.08

Fish oil, alcohol, and liver pathology: role of cytochrome P450 2E1. Proc Soc Exp Biol Med (1994) 1.08

Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus. Rheumatology (Oxford) (2008) 1.08

Dietary linoleic acid is required for development of experimentally induced alcoholic liver injury. Life Sci (1989) 1.07

Effects of chronic ethanol administration on rat liver proteasome activities: relationship with oxidative stress. Hepatology (1999) 1.07

Bile duct changes in alcoholic liver disease. The Veterans Administration Cooperative Study Group. Liver (1993) 1.07

Ethanol-induced hepatic fibrosis in the rat: role of the amount of dietary fat. Alcohol Clin Exp Res (1986) 1.06

Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease. Life Sci (1995) 1.06

Nesidioblastosis coexisting with islet cell tumor and intraductal papillary mucinous hyperplasia. Arch Pathol Lab Med (2001) 1.06

Connections of intermediate filaments with the nuclear lamina and the cell periphery. Biol Cell (1987) 1.05

Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors. Hepatology (1995) 1.05

The cyclic pattern of blood alcohol levels during continuous ethanol feeding in rats: the effect of feeding S-adenosylmethionine. Exp Mol Pathol (2010) 1.05

Pancreatic hamartoma with Langerhans cell histiocytosis in a draining lymph node. Histopathology (1998) 1.04

Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann Rheum Dis (2004) 1.04

A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans' syndrome: immunological analysis of B cells, T cells and cytokines. Rheumatology (Oxford) (2008) 1.04

A case of chronic infantile type of fucosidosis: clinical and magnetic resonance image findings. Brain Dev (2000) 1.04

Aggresome formation in liver cells in response to different toxic mechanisms: role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin. Exp Mol Pathol (2001) 1.03

Potentiation of ethanol-induced pancreatic injury by dietary fat. Induction of chronic pancreatitis by alcohol in rats. Am J Pathol (1988) 1.03

Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats. Hepatology (1992) 1.03

Mitochondrial tRNA(Ile) mutation in fatal cardiomyopathy. Biochem Biophys Res Commun (1992) 1.03

Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. Am J Physiol (1997) 1.03

Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. Oncogene (2007) 1.02

Simultaneous quantification of prostaglandins in human synovial cell-cultured medium using liquid chromatography/tandem mass spectrometry. Prostaglandins Leukot Essent Fatty Acids (2002) 1.02

Effect of thioacetamide on the hepatic expression of gamma-glutamylcysteine synthetase subunits in the Rat. Toxicol Appl Pharmacol (1999) 1.02

Identification of the 150-kDa surface antigen of Entamoeba histolytica as a galactose- and N-acetyl-D-galactosamine-inhibitable lectin. Parasitol Res (1998) 1.01

Arachidonate 12-lipoxygenase is localized in neurons, glial cells, and endothelial cells of the canine brain. J Histochem Cytochem (1993) 1.01

Mallory-Denk bodies form when EZH2/H3K27me3 fails to methylate DNA in the nuclei of human and mice liver cells. Exp Mol Pathol (2012) 1.01

The ultrastructure of Mallory body filaments. Lab Invest (1973) 1.01

Gastric cancer with metastases to the distant peritoneum: a 20-year surgical experience. Hepatogastroenterology (1998) 1.00

Dexamethasone enhances mallory body formation in drug-primed mouse liver. Exp Mol Pathol (2000) 1.00

Biochemical basis for analgesic activity of morphine-6-glucuronide. I. Penetration of morphine-6-glucuronide in the brain of rats. Biochem Pharmacol (1973) 1.00

Cellular origin of gastrointestinal stromal tumors: a study of 27 cases. Arch Pathol Lab Med (2000) 0.98

Oxidative stress and liver disease. Prog Liver Dis (1996) 0.98

Gastric adenocarcinoma with a yolk sac component: a case report and review of the literature. J Clin Gastroenterol (2000) 0.98

Primitive neuroectodermal tumor of the pulmonary hilum in an adult. Ann Thorac Surg (2001) 0.98

Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy. Br J Cancer (1992) 0.98

Mallory body formation runs parallel to gamma-glutamyl transferase induction in hepatocytes of griseofulvin-fed mice. Hepatology (1983) 0.97

Molecular heterogeneity of Krabbe disease. J Inherit Metab Dis (1999) 0.97

Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. Lupus (2005) 0.97

Drug delivery of antisense molecules to the brain for treatment of Alzheimer's disease and cerebral AIDS. J Pharm Sci (1998) 0.95